Quantcast
Last updated on April 21, 2014 at 5:21 EDT

Latest Clinical trial Stories

2014-04-01 08:30:29

Webinar to Explore Cutting-Edge Use of Data Analytics that Challenges Traditional Approach to Feasibility Studies and Significantly Increases Predictability BURLINGTON, Mass., April 1, 2014 /PRNewswire/ -- inVentiv Clinical Trial Recruitment Solutions (iCTRS), created to accelerate trials efficiently and predictably, will discuss the latest innovations in trial feasibility during a webinar next week hosted by Clinical Informatics News. Otis Johnson, executive director of...

2014-04-01 08:28:50

New investigational PCSK9 inhibitor shown to significantly reduce LDL-C among Japanese patients BRIDGEWATER, N.J. and TARRYTOWN, N.Y., April 1, 2014 /PRNewswire/ -- Sanofi (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the first Phase 2 study with alirocumab, an investigational monoclonal antibody targeting PCSK9 (proprotein convertase subtilisin/kexin type 9), in Japanese patients met its primary endpoint. The results...

2014-04-01 08:28:44

SAN DIEGO, April 1, 2014 /PRNewswire/ -- Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, today announced that clinical data from a study using the company's cancer monitoring platform for the detection and longitudinal monitoring of BRAF V600E mutations will be the subject of a late-breaking poster presentation at the American Association for Cancer Research Annual Meeting in San Diego, California....

2014-03-31 23:37:07

Top Tier Panelists from Onyx Pharmaceuticals, BioMarin Pharmaceutical, San Francisco State University, and Clinovo Share Experience on How to Conduct Successful Outsourcing Strategies Sunnyvale, CA (PRWEB) March 31, 2014 Outsourcing experts from Onyx Pharmaceuticals, San Francisco State University (SFSU), BioMarin Pharmaceutical, and Clinovo discussed the topic 'Manage In-house and Outsourced Clinical Trials: Vendor Selection, Project Coordination, and Resource Management' at the...

2014-03-31 23:32:30

Combined companies provide unrivalled capabilities for adaptive and medical device trials worldwide. Reston, Virginia (PRWEB) March 31, 2014 Aptiv Solutions, a global biopharmaceutical and medical device development services company leading the design and implementation of innovative approaches that improve data quality, efficiency, and productivity of product development today announced that it has agreed, subject to certain closing conditions, to be acquired by ICON plc, (NASDAQ: ICLR),...

2014-03-31 16:27:39

LA JOLLA, Calif., March 31, 2014 /PRNewswire/ -- Auspex Pharmaceuticals, Inc. (Nasdaq: ASPX), a late clinical stage biopharmaceutical company focused on developing and commercializing novel medicines for the treatment of orphan diseases, today announced that the Company was added to the Russell 2000® Index (as well as the larger Russell 3000® Index) at the close of market on March 31, 2014 as part of the quarterly Initial Public Offering (IPO) update to the Russell indexes. The...

2014-03-31 16:27:19

CRANBURY, N.J., March 31, 2014 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that it has granted an extension until April 30, 2014 to an existing option agreement with a potential commercial partner for an exclusive license to bremelanotide for female sexual dysfunction indications in...

2014-03-31 13:41:48

The 6-month follow-up data from the METOCARD-CNIC trial are published today in the Journal of the American College of Cardiology The initial results of this trial were published a few months ago (Circulation. 2013;128:1495-1503), and showed that patients who received this treatment during emergency transit to hospital had much smaller amounts of dead heart muscle than those randomly assigned to receive no treatment. The new study shows that the proportion of patients with a severely...

2014-03-31 08:29:05

MELBOURNE, Australia, March 31, 2014 /PRNewswire/ -- Prana Biotechnology (ASX:PBT/NASDAQ:PRAN) has today released the top line results of the 12-month Phase II Imaging trial in Alzheimer's Disease ("IMAGINE" Trial), based on draft results. Prana's PBT2 did not meet its primary endpoint of a statistically significant reduction in the levels of beta-amyloid plaques in the brains of prodromal/mild Alzheimer's disease patients, as measured using PiB-PET Standardized Uptake Value...

2014-03-28 23:25:53

Verified Clinical Trials is proud to announce their presence at the Partnerships In Clinical Trials meeting in Las Vegas, Nevada to discuss the largest North American clinical research volunteer database that stops dual enrollment in clinical trials, while promoting patient safety and data quality. VCT is partnered with the world's largest pharmaceutical companies and CROs and continues to grow at an exponential pace in an effort to eliminate the professional research subject. Garden...